John Renger
2020
In 2020, John Renger earned a total compensation of $1.8M as Chief Scientific Officer at Cerevel Therapeutics Holdings, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $266,400 |
|---|---|
| Option Awards | $900,000 |
| Salary | $450,000 |
| Other | $228,675 |
| Total | $1,845,075 |
Renger received $900K in option awards, accounting for 49% of the total pay in 2020.
Renger also received $266.4K in non-equity incentive plan, $450K in salary and $228.7K in other compensation.
Rankings
In 2020, John Renger's compensation ranked 5,890th out of 13,090 executives tracked by ExecPay. In other words, Renger earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,890 out of 13,090 | 55th |
Division Manufacturing | 2,417 out of 5,621 | 57th |
Major group Chemicals And Allied Products | 964 out of 2,254 | 57th |
Industry group Drugs | 835 out of 1,954 | 57th |
Industry Pharmaceutical Preparations | 623 out of 1,459 | 57th |
Source: SEC filing on April 28, 2021.
Renger's colleagues
We found four more compensation records of executives who worked with John Renger at Cerevel Therapeutics Holdings in 2020.